Bull&Bear | Globalstar Soars 1459% Amid Satellite Contract, Fluence Energy Plunges 46% on Earnings Guidance

Bullish Stocks:

Globalstar (GSAT) surged by 1459.62%, continuing its two-day rally with a total increase of 1511.26% over the last two days. The stock price of Globalstar rose following the signing of a definitive contract with MDA Space, making the company the primary contractor for the next-generation low Earth orbit constellation of satellite operators.

SelectQuote (SLQT) rose by 31.05%, continuing a two-day rally with a total gain of 31.05% over the period. SelectQuote raised its revenue forecast for fiscal year 2025 to between $1.5 billion and $1.575 billion, citing strong performance in the Medicare Advantage sector.

Anterix (ATEX) saw a rise of 26.79%. Anterix reported its third-quarter earnings for fiscal year 2025, with spectrum revenue amounting to $1.566 million, a net profit of $7.71 million, and a pre-tax profit of $7.476 million for the quarter.

MYT Netherlands (MYTE) increased by 24.30%, marking a four-day rally with a total gain of 33.51% over the last four days. The stock of MYT Netherlands' parent company rose due to strong sales growth.

Genelux (GNLX) gained 23.85%, sustaining a two-day rally with a total rise of 32.24% over the period. Genelux Corp announced the appointment of Matthew Pulisic as the new Chief Financial Officer, effective from January 30. Pulisic previously held a significant position at Arrowhead Pharma.

Bearish Stocks:

Fluence Energy (FLNC) declined by 46.44%. Fluence Energy, Inc. released its first-quarter earnings report for 2025 and lowered its full-year guidance despite reporting a record order backlog of $5.1 billion.

Columbus McKinnon (CMCO) dropped by 41.18%. The stock price of Columbus McKinnon fell following a downgrade by DA Davidson.

Third Harmonic Bio (THRD) decreased by 30.11%, continuing a three-day decline with a total loss of 36.52% over the period. Morgan Stanley downgraded Third Harmonic Bio to a hold rating and reduced its target price to $5.

Ceragon Networks (CRNT) fell by 21.46%, experiencing a four-day downtrend with a cumulative decline of 29.80% over the period. Ceragon Networks' stock dropped by more than 17%, expected to mark the largest percentage drop since March 2020, according to data analysis. The company released its fourth-quarter financial results, contributing to the downturn.

Voyager Therapeutics (VYGR) decreased by 20.96%, witnessing a four-day downward trend with a total decline of 25.71% over the period. The stock of Voyager Therapeutics fell after the decision to abandon the mid-2025 VY9323 IND submission plan.